BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Exactech AI Ecosystem of Smart Solutions to be Showcased at the 2024 AAOS Annual Meeting - Booth 951

  Exactech will showcase a full lineup of innovative implants and enabling technologies this week at the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting, Booth 951, in San Francisco, Ca.

  February 12, 2024

   · 

  2 min read
• Drug Development

  Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results

  Resolve Therapeutics, a mid-stage clinical development biotechnology company pioneering first-in-class therapies for autoimmune diseases, today announced the publication of results from its phase 2a clinical trial of RSLV-132 in patients with Systemic Lupus Erythematosus (SLE) in Lupus Science & Medicine.

  February 12, 2024

   · 

  2 min read
• Biotech Bay

  RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024

  RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced the publication of the TIMELESS trial in the New England Journal of Medicine (NEJM).

  February 12, 2024

   · 

  4 min read
• Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx

  Key regulatory milestone advances company’s mission to perfect cancer diagnosis

  February 12, 2024

   · 

  2 min read
• Biotech Bay

  Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024

  Jaya Biosciences, Inc. reported non-clinical data at the 20th Annual WORLD Symposium ™.

  February 12, 2024

   · 

  5 min read
• Biotech Bay

  Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089

  Nuvig Therapeutics, Inc. today announced the first-in-human dosing of NVG-2089, a proprietary product being developed to treat patients with inflammatory myopathies and severe dermatologic autoimmune disease.

  February 12, 2024

   · 

  2 min read
• Business

  David Bruning Named Chief Executive Officer of StageBio

  StageBio is pleased to announce the appointment of David Bruning as Chief Executive Officer.

  February 12, 2024

   · 

  3 min read
• BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

  BioHarvest Sciences Inc. a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and sponsorship of the 2024 BIO CEO & Investor Conference, which will take place in New York City from February 26-27, 2024.

  February 12, 2024

   · 

  3 min read
• HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS

  HTuO Biosciences announces it has joined Johnson & Johnson Innovation - JLABS as a resident virtual company.

  February 12, 2024

   · 

  1 min read
• Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³

  CSL Limited announces a reported net profit after tax of $1.90 billion for the 6 months ended 31 December 2023, up 20% on a constant currency basis.

  February 12, 2024

   · 

  11 min read